Showing results (81-90 of 94) with videos related to
Sort By:
Pageof 10
Cancer|March 11, 2003
Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single centerManuela F Azzola, Helen M Shaw, John F Thompson, et al.The British Journal of Surgery|October 11, 2008
Follow-up schedules after treatment for malignant melanomaA B Francken, N A Accortt, H M Shaw, et al.Annals of Surgical Oncology|July 16, 2005
A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanomaDaan van Poll, John F Thompson, Marjorie H Colman, et al.Annals of Surgical Oncology|June 7, 2012
The management of cervical lymph nodes in patients with cutaneous melanomaR C W Martin, K F Shannon, M J Quinn, et al.Oncogene|May 8, 2009
Tie2-mediated multidrug resistance in malignant gliomas is associated with upregulation of ABC transportersV Martin, J Xu, S K Pabbisetty, et al.Physical Review Letters|August 7, 2012
Kapellasite: a kagome quantum spin liquid with competing interactionsB Fåk, E Kermarrec, L Messio, et al.Annals of Surgical Oncology|April 9, 2004
The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-upAnne Brecht Francken, Helen M Shaw, John F Thompson, et al.Journal of Neuro-Oncology|June 27, 2008
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastomaJ F de Groot, M R Gilbert, K Aldape, et al.Nature Chemistry|June 24, 2017
Redox-controlled potassium intercalation into two polyaromatic hydrocarbon solidsF Denis Romero, M J Pitcher, C I Hiley, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2004
Determinants of outcome in melanoma patients with cerebral metastasesK M Fife, M H Colman, G N Stevens, et al.Pageof 10